Comparison of whole transcriptome RNA sequencing analysis in patients with HER2+ and HER2− identified unique immune-related pathways including macrophage activation, and T-cell response as well as cancer-related pathways including Wnt signaling and MYC-related pathways. The gene discussed is ERBB2; the disease is cancer.